N. Anderson
- Otorhinolaryngology top 10%
- Oncology top 10%
- Neutropenia and Cancer Infections 4
- Colorectal Cancer Treatments and Studies 3
- Cancer Treatment and Pharmacology 3
- Lung Cancer Research Studies 3
-
- Chemotherapy-induced organ toxicity mitigation 4
-
- Lung Cancer Treatments and Mutations 3
-
- Neuroendocrine Tumor Research Advances 4
-
- Cancer therapeutics and mechanisms 3
- Co-authors
- Jacob J. LokichMurray M. BernH S GarewalRudolph M. NavariStefan MadajewiczThomas BeckBarry GreenbergKaren Caldwell
- Partner nations
- United StatesAustralia
In The Last Decade
N. Anderson
16 papers receiving 437 citations
Peers
Comparison fields: 5 of 77
- Otorhinolaryngology 39
- Oncology 240
- Pathology and Forensic Medicine 68
- Surgery 151
- Pulmonary and Respiratory Medicine 98
Countries citing papers authored by N. Anderson
This map shows the geographic impact of N. Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Anderson more than expected).
Fields of papers citing papers by N. Anderson
This network shows the impact of papers produced by N. Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Anderson. The network helps show where N. Anderson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside N. Anderson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 1 | |
| 4 | 1998 | 2 | |
| 5 | 1998 | 9 | |
| 6 | 1998 | 233 | |
| 7 | 1998 | 11 | |
| 8 | 1997 | 29 | |
| 9 | Pilot study of ambulatory infusional delivery of a multidrug regimen: ifosfamide, carboplatin and etoposide (ICE). | 1996 | 0 |
| 10 | 1995 | 68 | |
| 11 | 1995 | 6 | |
| 12 | 1992 | 2 | |
| 13 | Controversial issues in 5-fluorouracil infusion use. Dose intensity, treatment duration, and cost comparisons. | 1992 | 36 |
| 14 | 1991 | 4 | |
| 15 | 1991 | 11 | |
| 16 | 1991 | 6 | |
| 17 | 1991 | 14 | |
| 18 | 1989 | 29 | |
| 19 | 1980 | 11 |
About N. Anderson
N. Anderson is a scholar working on Oncology, Transplantation and Occupational Therapy, having authored 19 papers that have together received 473 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (4 papers), Neutropenia and Cancer Infections (4 papers), Chemotherapy-induced organ toxicity mitigation (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer Treatment and Pharmacology (3 papers), Lung Cancer Research Studies (3 papers), Cancer therapeutics and mechanisms (3 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Otorhinolaryngology (39 citations), Oncology (240 citations) and Pathology and Forensic Medicine (68 citations). N. Anderson has collaborated with scholars based in United States and Australia. Frequent co-authors include Jacob J. Lokich, Murray M. Bern, H S Garewal, Rudolph M. Navari, Stefan Madajewicz, Thomas Beck, Barry Greenberg, Karen Caldwell, N. Simon Tchekmedyian and A. Y. Chang. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.